{
    "organizations": [],
    "uuid": "706cc3384bcc84ade4e21118affdd5d8858f9397",
    "author": "",
    "url": "https://www.reuters.com/article/brief-iridian-asset-management-llc-repor/brief-iridian-asset-management-llc-reports-10-1-pct-passive-stake-in-eagle-pharmaceuticals-as-of-dec-31-2017-sec-filing-idUSFWN1P30XU",
    "ord_in_thread": 0,
    "title": "BRIEF-Iridian Asset Management LLC Reports 10.1 Pct Passive Stake In Eagle Pharmaceuticals As Of Dec. 31, 2017 - SEC Filing‍​",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 8 (Reuters) - Eagle Pharmaceuticals Inc:\n* IRIDIAN ASSET MANAGEMENT LLC REPORTS 10.1 PERCENT PASSIVE STAKE IN EAGLE PHARMACEUTICALS INC AS OF DEC. 31, 2017 - SEC FILING‍​ Source text: ( bit.ly/2En48mt ) Further company coverage:\n ",
    "published": "2018-01-08T23:47:00.000+02:00",
    "crawled": "2018-01-09T09:35:57.614+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "eagle",
        "pharmaceutical",
        "inc",
        "iridian",
        "asset",
        "management",
        "llc",
        "report",
        "percent",
        "passive",
        "stake",
        "eagle",
        "pharmaceutical",
        "inc",
        "sec",
        "source",
        "text",
        "company",
        "coverage"
    ]
}